Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

A systematic approach is crucial for managing hair loss in women.

Higher iron levels in the blood are not linked to increased hair loss in women.

Women with thinning hair have thinner hair strands than women without hair loss.

Hair growth dysfunction involves various conditions with limited treatment options.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The dietary supplement helped increase hair growth in women with hair loss.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Effective hair loss assessment requires a mix of precise measurement methods.

Healthy women tend to lose more hair in July and April, and the least in February.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Proteins from stem cells improved hair growth in patients with hair loss.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

The Bcl-2 protein is important for keeping hair follicle stem cells working and preventing hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.